Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 157 (2) , 202-206
Abstract
A range of cutaneous manifestations, including chilblain-like lesions, have been described in association with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection during the coronavirus 2019 (COVID-19) pandemic.1 Chilblain-like lesions have been occurring more frequently than expected, and studies have begun to explore the potential link with SARS-CoV-2 infection vs other plausible etiologies.2-4 The aim of this case series was to perform a systematic, prospective evaluation of patients presenting with chilblain-like lesions to characterize this condition occurring during the COVID-19 pandemic.Keywords
This publication has 12 references indexed in Scilit:
- Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicJAMA Dermatology, 2020
- Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 PandemicJAMA Dermatology, 2020
- A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain‐like lesions: lights and shadows on the relationship with COVID‐19 infectionJournal of the European Academy of Dermatology and Venereology, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020
- An Update on Autoinflammatory Diseases: InterferonopathiesCurrent Rheumatology Reports, 2018
- Genetic interferonopathies: An overviewBest Practice & Research Clinical Rheumatology, 2017
- Type I interferonopathies in pediatric rheumatologyPediatric Rheumatology, 2016
- Type I interferons in infectious diseaseNature Reviews Immunology, 2015